Cargando…
The affinity, intrinsic activity and selectivity of a structurally novel EP(2) receptor agonist at human prostanoid receptors
BACKGROUND AND PURPOSE: Prostanoid EP(2) receptor agonists exhibit several activities including ocular hypotension, tocolysis and anti‐inflammatory activity. This report describes the affinity and selectivity of a structurally novel, non‐prostanoid EP(2) receptor agonist, PGN‐9856, and its therapeut...
Autores principales: | Coleman, R A, Woodrooffe, A J, Clark, K L, Toris, C B, Fan, S, Wang, J W, Woodward, D F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365485/ https://www.ncbi.nlm.nih.gov/pubmed/30341781 http://dx.doi.org/10.1111/bph.14525 |
Ejemplares similares
-
Improved homology modeling of the human & rat EP(4) prostanoid receptors
por: Holt, Melissa C., et al.
Publicado: (2019) -
E-type prostanoid receptor 4 (EP4) in disease and therapy
por: Konya, Viktoria, et al.
Publicado: (2013) -
Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation
por: Philipose, Sonia, et al.
Publicado: (2012) -
Laropiprant attenuates EP(3) and TP prostanoid receptor-mediated thrombus formation
por: Philipose, Sonia, et al.
Publicado: (2012) -
The Gαs‐protein‐mediated pathway may be steadily stimulated by prostanoid EP2 receptors, but not by EP4 receptors
por: Fukushima, Keijo, et al.
Publicado: (2022)